Estriol Cream for Menopause: What It Helps, What It Doesn't, and Why No U.S. Version Is FDA-Approved

Q: Is estriol cream available over the counter in the United States?

There is no FDA-approved over-the-counter estriol drug in the United States. Unapproved products can still appear online and in drug-label databases. A current DailyMed entry, for example, labels micronized estriol 0.1% as a “Human OTC Drug Label” while also marking its marketing status “unapproved drug other.” That is availability without approval. (DailyMed example)

The HRT Index Editorial TeamIndependent women's health research

Published:August 31, 2026Last reviewed:August 31, 2026

Editorial research — not medically reviewed by a clinician. Why this label

Last updated: August 31, 2026 · Last verified: August 31, 2026 · By The HRT Index Editorial Team. Educational research, not medical advice, and not reviewed by a clinician. See our medical review policy. Full disclosure.

Before you pay for an estriol product

Start by identifying whether you need local vaginal treatment, systemic HRT, a face product, or an in-person evaluation. The free path tool can flag when online care is not the right starting point.

Find the route that fits your situation

Some links on this page are affiliate links. Midi Health, Winona, Sesame, and Inner Balance are current affiliate partners. Hone Health and Alloy are not. That does not change which route we recommend, and the nonpaying option is sometimes the better answer.

Estriol cream for menopause can help certain vaginal and urinary symptoms when the exact product and dose fit the problem. But no estriol-containing drug is FDA-approved in the United States. Prescribed U.S. estriol is generally compounded, while unapproved commercial listings also exist. Before paying, identify the route, concentration, pharmacy, and FDA-approved alternatives.

Best for / not for you if

Worth reading, and worth considering, if:

You have vaginal dryness, burning, irritation, pain with sex, urinary urgency, or recurrent urinary tract infections.
Over-the-counter moisturizers and lubricants were not enough.
Someone told you estriol is “gentler,” and you want to know what that does—and does not—mean.
You were offered compounded estriol or “Bi-Est” and want to know what to ask before paying.
You found an estriol product online and cannot tell whether it belongs in the vagina, on the body, or on the face.

Not for you if:

You have unexplained bleeding after menopause. Stop reading product pages and get evaluated in person. That symptom needs a workup, not a checkout button.
You have severe or new pelvic pain, blood in your urine, foul-smelling discharge, fever, or symptoms that may be an infection.
You have a history of estrogen-dependent cancer or take tamoxifen or an aromatase inhibitor and want a website to make the decision for you. This belongs in a shared decision with your gynecologist and cancer team.
Your main problem is hot flashes or night sweats. Low-dose local vaginal treatment is the wrong category for those symptoms.
You want a face cream. That is a different product with a different job; see our prescription estriol face cream guide.

The number that decides most of this page

FDA-approved estriol-containing drug products in the United States: 0.

The FDA says there are no FDA-approved drugs containing estriol.

Your situation, in one table

What is going on	What that means here
Dryness, burning, pain with sex, urinary urgency, or recurrent UTIs	A local vaginal treatment may fit. The exact product, dose, and diagnosis matter next.
Hot flashes, night sweats, or whole-body symptoms	A low-dose local vaginal cream is the wrong treatment category. You are looking at systemic or nonhormonal therapy.
You found a U.S. prescription estriol product	It is generally a compounded drug, not an FDA-approved drug.
You found an estriol product sold directly online	It may be an unapproved commercial listing rather than a patient-specific compounded prescription.
You saw an NDC number or a DailyMed page	Neither proves FDA approval.
You have unexplained postmenopausal bleeding, severe pelvic pain, or suspected infection	Pause the product search and seek in-person care first.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

“Estriol cream” is three different creams—and a fourth category that looks official but is not approved

Estriol, also written E3, is one of the estrogens made by the human body. But an “estriol cream” search can surface a local vaginal prescription, a systemic Bi-Est body cream, a prescription face cream, or an unapproved commercial product. Those are not four strengths of one medicine. They have different routes, intended effects, evidence, and regulatory status.

This is the single biggest source of confusion in the category. You can open two tabs, see “estriol” on both, and be looking at products that have almost nothing to do with each other.

Here is the map we wish every product page showed first.

What you found	Where it goes	Job it is meant to do	What is usually in it	U.S. status	What to verify before paying
Compounded vaginal estriol cream	Inside the vagina, sometimes with separate external directions	Local vaginal and urinary menopause symptoms	Estriol alone or a patient-specific combination	Compounded prescription; not FDA-approved	Estriol concentration, grams per application, pharmacy, route, loading and maintenance schedule
Bi-Est body cream	Skin such as forearms, thighs, or abdomen	Systemic menopause treatment for whole-body symptoms	Estriol plus estradiol, sometimes with separate progesterone	Compounded prescription; not FDA-approved	Total milligrams of each estrogen per pump, systemic plan, uterus/progesterone plan, age and state eligibility
Estriol face cream	Face or neck as directed	Cosmetic skin concerns	Estriol, sometimes with tretinoin or other dermatology ingredients	Compounded prescription; not FDA-approved	Concentration, other actives, package size, pregnancy precautions, and why this route fits
Unapproved commercial or “OTC” estriol cream	Label-dependent; may be external-only despite vaginal marketing	Marketing claims vary	Estriol concentration may be listed, but dose and intended route may remain unclear	Not FDA-approved; may appear in DailyMed or carry an NDC	Marketing status, internal versus external use, accountable seller, clinician involvement, approval record, and safety warnings

How to tell in ten seconds which one you found

Did the label show an applicator and say intravaginal use? You are looking at a vaginal product.
Did it say pumps to the arms, thighs, abdomen, or forearms? That is systemic hormone therapy in a tube.
Did it mention wrinkles, collagen, elasticity, fine lines, or “glow”? That is a face product.
Did it say Bi-Est or give a ratio such as 50/50 or 80/20? It contains estriol plus estradiol and is usually intended for systemic treatment.
Did it carry an NDC number but no prescription pathway, pharmacy, or FDA approval record? Treat it as an unapproved listing until proven otherwise.

Safety line, stated once and plainly: do not use a face or body cream inside the vagina, and do not use a vaginal cream on your face, unless the actual prescription label and prescriber direct that route. The bases, concentrations, application amounts, and intended absorption differ. “It contains the same hormone” is not a reason.

Two product names that cause avoidable confusion

Oestra is not an estriol product. Inner Balance currently lists Oestra as a vaginally administered systemic compounded cream containing 3 mg estradiol plus 100 mg micronized progesterone per pump. Inner Balance separately sells a face cream containing 0.3% estriol. Read the active ingredients, not a card heading or a similar-sounding name. (Inner Balance Oestra product page; Inner Balance face cream page)

Winona's Estrogen Body Cream is not a vaginal estriol cream. Its current public page describes a compounded 50/50 estradiol-and-estriol Bi-Est cream applied to the skin for systemic symptoms. (Winona Estrogen Body Cream)

Not sure which cream you found? Use Find My HRT Path to sort whether your symptoms point toward local vaginal treatment, systemic HRT, or an in-person evaluation before you choose a product.

Is estriol cream for menopause FDA-approved in the United States?

No. The FDA states that no drug containing estriol is FDA-approved in the United States. A patient-specific compounded estriol prescription can meet a legitimate clinical need, but the finished compounded drug is not FDA-approved and FDA does not verify its safety, effectiveness, or quality before it is marketed.

This is the fact the whole page turns on, so here is the primary-source trail.

The direct FDA answer

The FDA's menopause guidance says:

No FDA-approved drug contains estriol.
FDA does not have evidence that estriol drugs are safer forms of estrogen.
Compounded “bioidentical” drugs are not FDA-approved.
FDA recommends FDA-approved hormone therapies when an approved option meets the patient's needs.

The FDA's compounding Q&A also states that compounded drugs are not FDA-approved and that FDA does not verify the finished product's safety, effectiveness, or quality before marketing. FDA recognizes that compounding can serve an important need when an approved medication is not medically appropriate for a specific patient.

The asterisk check you can reproduce

The 503B Category 1 bulk-substances list available when we checked was updated March 21, 2025. On that document, two asterisks identify substances that are components of FDA-approved drugs. The relevant sequence reads:

Estradiol**
Estradiol cypionate**
Estriol
Estrone**

Estriol appears without the asterisks. The same document places it in the category of bulk substances still under evaluation for 503B outsourcing-facility use. That list is not itself an approval list, but its formatting independently confirms the central point: estriol is not a component of an FDA-approved estriol drug. (FDA 503B bulk-substances list)

How compounding can still be legitimate

“Not FDA-approved” and “cannot be prescribed” are not the same statement.

Federal law recognizes different compounding pathways:

Section 503A generally covers qualifying patient-specific compounding by a licensed pharmacist in a state-licensed pharmacy or federal facility, or by a physician.
Section 503B covers registered outsourcing facilities operating under a different federal framework and current good manufacturing practice requirements.

State boards generally oversee day-to-day practice at ordinary state-licensed pharmacies; FDA has separate federal authority and more direct oversight of registered 503B outsourcing facilities. Neither pathway turns a compounded finished drug into an FDA-approved drug. (FDA compounding Q&A)

A serious online service should tell you the name of the dispensing pharmacy and whether your medication is a patient-specific compounded prescription. FDA warns that people buying compounded drugs through telehealth may not know who actually made the drug or whether that compounder is appropriately licensed and regulated.

The fair half of the story

Estriol is not imaginary or fringe. Licensed vaginal estriol medicines exist outside the United States.

Two current examples show why the exact product matters:

Licensed product example	Concentration	Estriol per labeled application	Initial schedule in its own label	Maintenance in its own label
Blissel vaginal gel	50 micrograms per gram	0.05 mg from a 1 g application	Daily for 3 weeks	Twice weekly
Estriol 1 mg/g cream / Ovesse	1 mg per gram	0.5 mg from a 0.5 g application	Daily for 2–4 weeks, depending on the named product	Twice weekly

Source: Spanish regulator's Blissel label, Estriol 1 mg/g cream SmPC, and Ovesse SmPC.

So when a woman in Europe says her clinician prescribed estriol vaginal cream, she may be describing a licensed medicine with a fixed label. A U.S. compounded prescription is a different finished product under a different regulatory system.

The damaging admission

A clinician can have a sound patient-specific reason to choose compounded estriol. But no amount of “bioidentical,” “European,” “pharmacy made,” or “doctor formulated” turns the finished U.S. cream into an FDA-approved drug.

If an FDA-approved local option can meet the same need, it is easier to authenticate: the active ingredient, strength, directions, manufacturing standards, contraindications, and adverse-effect information are attached to one identified product. If it cannot meet the need, the compounded route has to earn your trust with a clear clinical reason and a clear formula.

Does an NDC number or DailyMed listing mean estriol cream is FDA-approved?

No. DailyMed displays labels for approved and unapproved products, and FDA says the presence or assignment of a National Drug Code does not denote approval. A current estriol listing can therefore look official, carry an NDC, and still say in its own marketing-status field that it is an unapproved drug.

This is the exact place where careful research can create false confidence.

What each signal proves—and what it does not

What you saw	What it establishes	What it does not establish
An NDC number	The product has an identifier in the National Drug Code system	FDA approval, safety, effectiveness, or an approved label
A DailyMed page	Labeling was submitted and is displayed in the federal label repository	FDA approval; DailyMed also displays unapproved products
“Made with FDA-approved ingredients”	At most, a claim about a source ingredient or supplier	Approval of the finished compounded product
“Compounded in a licensed U.S. pharmacy”	A state pharmacy license may exist	FDA approval of the drug or proof that the formulation fits you
“Bioidentical”	A chemical-structure description	Approval, superiority, dose consistency, or lower risk
“Used in Europe”	Licensed estriol products exist in some countries	U.S. approval or equivalence to an unnamed U.S. compound

The FDA's NDC Directory page says directly that inclusion in the directory or assignment of an NDC number does not denote FDA approval.

A current example, checked August 2026

A current DailyMed listing for a micronized estriol 0.1% cream shows:

Product category: Human OTC Drug Label
Marketing status: Unapproved drug other
Route: Topical
Label direction: External use only; do not use internally
An explicit disclaimer that FDA has not approved the labeling

That listing was updated June 14, 2026. It is the cleanest proof that two statements can be true at once: no FDA-approved OTC estriol exists, and unapproved commercial estriol products can still appear online. (Current DailyMed estriol listing)

Federal regulations also state that OTC topical hormone-containing drug products are not generally recognized as safe and effective for OTC use. (21 CFR 310.530)

The one-sentence version: an official-looking database entry can prove that a label exists. It cannot prove that FDA approved the product.

Is estriol really “gentler” or safer than estradiol?

Estriol is often described as a weaker or gentler estrogen, but that description does not prove that a product is safer. Dose, route, concentration, application amount, formulation, and the woman using it all change exposure. Published pharmacokinetic research confirms that vaginal estriol can reach the bloodstream and that levels vary widely between women.

This claim is the marketing engine of the category, so it deserves a harder test than a slogan.

Claim	What survives verification
“Estriol is the gentle estrogen.”	It may be reasonable shorthand for lower estrogenic potency in some contexts. It is not a clinical safety verdict for an unknown dose and route.
“Local means it stays entirely local.”	False. Local treatment is intended to act mainly at the application site, but systemic absorption is not necessarily zero.
“Bioidentical means safer.”	Unsupported. FDA does not consider compounded bioidentical hormones automatically safer or more effective than approved products.
“The active ingredient is FDA-approved.”	FDA approves finished drug products, not a compounded product by association. Estriol is not contained in any FDA-approved drug.
“European use proves this U.S. compound is equivalent.”	False. Evidence belongs to the studied product, dose, route, and manufacturing system.

A 2021 pharmacokinetic study of chronic users of 0.5 mg vaginal estriol cream found peak serum estriol around two hours after application, with wide variation between users. The point is not that the treatment is “systemic HRT.” The point is that “zero absorption” is not an honest blanket claim. (te West et al., British Journal of Clinical Pharmacology)

The sentence worth remembering

“Gentler” is a dose statement wearing a molecule's clothes.

A 0.05 mg estriol application and a 0.5 mg estriol application contain the same hormone at a ten-fold different dose. The name alone cannot tell you which one you are getting.

A current affiliate claim we will not repeat

Winona currently states that all 503A pharmacies must compound with “FDA-approved ingredients.” Its own page also correctly says Winona's compounded treatments are not FDA-approved. But FDA's current menopause guidance says no FDA-approved drug contains estriol.

We will not describe estriol as an “FDA-approved ingredient.” The accurate statement is simpler: Winona's estriol-containing creams are compounded finished drugs and are not FDA-approved. (Winona's current FDA-status page; FDA menopause guidance)

That correction does not make Winona illegitimate. It keeps an approval claim from being stretched past what FDA actually says.

How much estriol is actually in these creams?

The named licensed vaginal products we could verify span 0.05 mg to 0.5 mg of estriol per application—a ten-fold range before U.S. compounds enter the picture. Several U.S. seller pages publish a price but not the estriol concentration or milligrams per application, so a reader cannot place the product on the evidence map before checkout.

We converted every current, directly verifiable product label into the same unit: milligrams of estriol per application.

Product or source	Concentration	Application amount	Estriol placed per application	What this number can tell you
Blissel vaginal gel	0.005% = 0.05 mg/g	1 g	0.05 mg	Product-specific ultra-low-dose licensed regimen
Estriol 1 mg/g cream / Ovesse	0.1% = 1 mg/g	0.5 g	0.5 mg	Product-specific licensed regimen
Current DailyMed unapproved estriol cream	0.1% = 1 mg/g	“2 pumps,” but pump mass is not published	Cannot calculate	Concentration alone is not a dose
Hone vaginal estriol cream	Not publicly stated on the product page	Not publicly stated	Cannot calculate	Price is visible; dose is not
Winona Bi-Est body cream	50/50 estradiol/estriol ratio	Personalized pumps	Cannot calculate from the public page	A ratio does not disclose milligrams

Source: Blissel product information, Estriol 1 mg/g cream SmPC, DailyMed unapproved estriol listing, Hone estriol page, and Winona body cream page.

The one skill that makes the numbers usable

A percentage is a concentration, not a dose.

1% = 10 mg per gram
0.1% = 1 mg per gram
0.05% = 0.5 mg per gram
0.005% = 0.05 mg per gram

Then:

Dose per application = concentration in mg/g × grams applied

A product that gives you a percentage but not the grams per application has not told you the dose.

The question to ask before you pay

“Please send me the exact formulation: every active ingredient, the concentration of each one, the amount applied per dose, the package size, and the name of the dispensing pharmacy.”

A legitimate patient-specific prescription will ultimately have those details on its dispensing label. Asking before the first charge is not difficult behavior. It is the fastest way to find out whether the product page is giving you information or just atmosphere.

Want to organize the decision before a consult? Get your personalized action plan with Find My HRT Path before checkout.

Does estriol cream work for vaginal dryness, painful sex, and recurrent UTIs?

Yes, specific vaginal estriol products have a real evidence base for vaginal and urinary menopause symptoms, and vaginal estrogen as a treatment class improves dryness, burning, painful sex, urgency, frequency, and recurrent-UTI risk in appropriate patients. That evidence belongs to the studied product and dose; it does not automatically validate an unidentified U.S. compound or marketplace cream.

Genitourinary syndrome of menopause (GSM) is the umbrella term for low-estrogen changes affecting the vulva, vagina, urethra, and bladder. The Menopause Society's position statement estimates that GSM affects 27% to 84% of postmenopausal women and can impair sexual function, comfort, urinary health, and quality of life. (The Menopause Society's 2020 GSM position statement)

What the evidence supports

A Society of Gynecologic Surgeons systematic review found that vaginal estrogens improved dryness, painful sex, urinary urgency and frequency, and recurrent UTIs compared with placebo, while common vaginal estrogen preparations generally had similar efficacy at the doses studied. (Rahn et al., Obstetrics & Gynecology)

The 2025 American Urological Association GSM guideline recommends local low-dose vaginal estrogen for vulvovaginal discomfort and painful sex and recommends it to reduce future urinary tract infections in peri- and postmenopausal women with recurrent UTIs, when appropriate. (AUA/SUFU/AUGS GSM guideline)

That supports five practical conclusions:

Dryness, burning, irritation, and pain with sex are legitimate treatment targets.
Urinary urgency and frequency can be part of GSM, but they still need the correct diagnosis.
Local vaginal estrogen can reduce future recurrent UTIs; it is not a treatment for a current untreated infection.
Nonhormonal moisturizers and lubricants remain reasonable first steps for milder symptoms.
The evidence cannot tell you whether an unknown compound works until you know its dose and route.

The evidence boundary most product pages skip

A study of a 0.05 mg licensed gel tells you about that gel. A study of a 0.5 mg licensed cream tells you about that cream. It does not tell you that:

A 0.1% external-use marketplace cream is safe for vaginal use.
A U.S. compound with an unpublished application amount matches a European label.
A Bi-Est body cream is interchangeable with local vaginal treatment.
A face cream has evidence for GSM because it contains estriol.

Evidence follows the formulation. It does not follow the word on the front of the tube.

Does estriol cream help hot flashes—and can you use it with systemic HRT?

A low-dose local vaginal estriol product is intended for vaginal and urinary symptoms, not hot flashes, night sweats, or osteoporosis prevention. A Bi-Est body cream is a different systemic treatment category. Some women need both local and systemic treatment, but stacking products without one clinician seeing the full list is how duplicate estrogen exposure happens.

Local symptoms and systemic symptoms are different decisions

Mostly local vaginal or urinary symptoms	Mostly systemic symptoms
Vaginal dryness	Hot flashes
Burning or itching	Night sweats
Pain with sex	Sleep disruption driven by vasomotor symptoms
Vulvar discomfort	Whole-body temperature symptoms
Urinary urgency, frequency, or recurrent UTIs	Bone-protection or broader systemic-treatment questions

If your main problem sits in the right column, a local cream will not solve it. Be skeptical of a small “vaginal” or external estriol product marketed as the answer to weight gain, every mood change, hot flashes, sleep, and whole-body “hormone balance.” That is not one treatment claim. It is a pile of different treatment claims attached to one tube.

You may need both

A woman can have hot flashes and painful sex at the same time. In that case, the right answer may be:

A systemic therapy for vasomotor symptoms.
A separate local therapy for persistent GSM.
A nonhormonal systemic option plus local vaginal treatment.
A nonhormonal local plan if estrogen is not the right choice.

The false choice is assuming one cream must do every job.

Before adding a product, write down:

Product name.
Every active ingredient.
Route.
Concentration or strength.
Amount per application.
Frequency.
Prescriber.
Dispensing pharmacy.
Symptom it is intended to treat.

Then ask:

“Which product is treating which symptom? Is each one local or systemic? What is my total estrogen exposure, and does my uterus status change the plan?”

Common blind spots include a patch plus a Bi-Est body cream, two estrogen products from different prescribers, or a face cream that never made it onto the medication list because it felt cosmetic.

If you have both systemic and vaginal symptoms, one-product telehealth can become the wrong tool. Midi Health is available in all 50 states and can build one care plan that includes FDA-approved systemic and local prescriptions when clinically appropriate. It is in-network with many PPO plans; current self-pay visit pricing is $250 for the first visit and $150 for continued-care visits, with medication costs separate.
→ Check Midi coverage and book a menopause visit
Midi currently cannot treat Medicaid or Medi-Cal patients. Medicare beneficiaries can use self-pay care but Midi says not to submit those charges to Medicare. (Midi pricing; Midi FAQ)

Can you use vaginal estriol after breast cancer or while taking an aromatase inhibitor?

This is not an automatic “never,” and it is not an online checkout decision. Current guidance starts with nonhormonal options, then allows low-dose vaginal estrogen to be considered after informed shared decision-making. For women taking an aromatase inhibitor, ACOG calls for a decision among the patient, gynecologist, and oncologist.

That is a meaningful correction to the blunt “no cream, no exceptions” advice that circulates online.

What current guidance says

ACOG states that if nonhormonal treatment has not adequately addressed symptoms, low-dose vaginal estrogen may be used after discussion of risks and benefits, including in women taking tamoxifen. For women taking an aromatase inhibitor, ACOG says low-dose vaginal estrogen can be used after shared decision-making among the patient, gynecologist, and oncologist. (ACOG Clinical Consensus)

That guidance concerns low-dose vaginal treatment as a category. It does not mean an oncology team will view every compounded estriol formula as equivalent.

Why the exact product matters more here

Research exists on specific ultra-low-dose estriol formulations in breast-cancer populations. But those findings cannot be borrowed by:

A compound with an unpublished strength.
A Bi-Est systemic body cream.
An external-use marketplace cream.
A face product.
A formula combined with other hormones without the oncology team knowing.

This is the highest-stakes version of the evidence rule: a studied dose is not a permission slip for an unidentified product.

Take these words to the clinician who knows your cancer history

“My vaginal or urinary symptoms are affecting my quality of life, and nonhormonal options have not been enough. Would you consider a low-dose vaginal treatment in my case? If yes, which exact product and dose do you want me to use, and do you want my oncologist involved?”

That question can produce a real, documented plan. A testimonial carousel cannot.

There is deliberately no affiliate CTA in this section.

If you have a uterus, do you need progesterone with estriol cream?

Routine progestogen is generally not recommended with recognized low-dose local vaginal estrogen regimens. But that answer cannot be stretched to a systemic Bi-Est body cream or an estriol compound whose dose and intended absorption are unclear. If the treatment is systemic and you have a uterus, endometrial protection is a live part of the plan.

The answer changes with four facts

Do you have a uterus?
Is the product truly local or intended to be systemic?
What is the exact estrogen dose and frequency?
Does the formula include estradiol or another estrogen in addition to estriol?

The Menopause Society's GSM position statement says a progestogen is not indicated when low-dose vaginal estrogen, vaginal DHEA, or ospemifene is used, while also noting that endometrial safety data beyond one year are limited. (The Menopause Society GSM statement)

Licensed low-dose estriol labels make product-specific statements about progestogen at their labeled maintenance regimens. Those statements belong to those named products and schedules—not every formula a U.S. pharmacy can make.

Where the answer changes

Bi-Est body cream: This is intended to create systemic exposure. If you have a uterus, ask exactly how your endometrium is being protected.
Unknown compounded strength: If you cannot confirm the dose, you cannot confirm that the product fits the “low-dose local” evidence bucket.
Compounded progesterone cream or gel: The British Menopause Society warns that transdermal micronized progesterone has variable absorption and may not provide sufficient endometrial protection. (BMS progestogen tool)
You already take progesterone with systemic estrogen: Do not stop it because you read that low-dose vaginal estrogen usually does not require added progestogen. Your progesterone may be protecting against the systemic estrogen.

Surgery language worth saying out loud

Do not reduce your history to “hysterectomy: yes/no” if the surgery was more specific.

Tell the prescriber if you had:

Endometrial ablation.
Supracervical hysterectomy.
Total hysterectomy.
Surgery for endometriosis.
Any procedure where you are unsure what tissue remains.

And the rule stays simple:

Any unexplained bleeding after menopause needs evaluation.

We go deeper in our guide to progesterone and vaginal estrogen.

How do you use estriol cream—and how long does it take to work?

Use the exact dispensing label and prescriber instructions. Estriol strengths, applicators, cream bases, loading schedules, maintenance schedules, and cleaning directions differ. Licensed European products commonly use a daily loading phase followed by twice-weekly maintenance, but those labels are examples for those products—not universal instructions for U.S. compounds.

Product-specific examples, not a prescription for you

Named licensed product	Labeled loading phase	Labeled maintenance	Product-specific note
Blissel 0.005% vaginal gel	One applicator daily for 3 weeks	Twice weekly	0.05 mg estriol per application
Estriol 1 mg/g cream	One applicator daily for the first weeks, with the exact duration set by the label and response	Twice weekly	0.5 mg estriol per 0.5 g application
Ovesse 1 mg/g cream	Daily for up to 4 weeks	Twice weekly	Same concentration; follow the named product's instructions

Source: Blissel label, Estriol 1 mg/g cream patient information, and Ovesse product information.

Do not take one of those schedules and apply it to a different U.S. compound. Your dispensing label should state:

Concentration.
Grams or applicator marking per dose.
Where to apply it.
How often to use it.
When to step down.
When the prescriber wants to review the response.

Applicator, finger, and external use are not interchangeable instructions

Use the applicator if the label directs an applicator. Use external application only if the label or prescriber gives external directions. Do not improvise internal use for a product labeled external-only.

If insertion is painful, difficult, or impossible, stop trying to force the applicator and tell the clinician. Pain, narrowing, pelvic-floor problems, dermatologic conditions, or another diagnosis may need a different approach.

Cleaning directions are product-specific

The current Estriol 1 mg/g cream leaflet instructs users to separate the plunger and barrel and wash them in hand-hot soapy water, avoiding boiling water and strong detergents. Your compound may use a different applicator and different instructions. Follow the leaflet that came with your product. (Estriol 1 mg/g cream leaflet)

Leakage and timing

Some cream may come back out. Bedtime application and a liner can make the format easier to live with when those steps fit the product directions. Heavy leakage, pain, or uncertainty that the dose stayed in place deserves a message to the prescriber rather than an extra dose.

Product information describes improvement over days to weeks, not overnight. Dryness or surface irritation may change before pain with sex or urinary symptoms. If you reach the planned review point without meaningful improvement, ask whether the diagnosis, dose, route, adherence, or product base needs to change.

Condoms and diaphragms

The FDA-approved Premarin Vaginal Cream label warns that exposure may weaken latex or rubber condoms, diaphragms, and cervical caps. That warning is product-specific; it does not prove that every estriol compound has the same effect. It does prove that the cream base can matter. Ask the dispensing pharmacy in writing if you depend on a barrier method. (Premarin Vaginal Cream label)

What side effects can happen—and what needs prompt attention?

Local irritation, itching, burning, discharge, leakage, breast tenderness, and spotting are listed across estriol product information and seller materials, but rates differ by formulation. No U.S. compounded estriol cream has an FDA-approved adverse-event table. New postmenopausal bleeding, severe pelvic symptoms, or signs of infection should not be normalized as “your body adjusting.”

Contact the prescriber

Contact the prescribing clinician for:

New spotting or bleeding.
Persistent local irritation.
Significant breast tenderness or a new breast concern.
Pelvic pain.
Worsening urinary symptoms.
A rash or reaction that may come from the cream base.
No meaningful improvement by the planned review.
Conflicting directions between the product page, portal, and dispensing label.

Get evaluated in person

Do not route these through a product checkout:

Unexplained bleeding after menopause.
Severe or new pelvic pain.
Blood in the urine.
Fever, foul-smelling discharge, or suspected infection.
A new breast mass or other concerning breast change.
Symptoms that persist despite months of treatment.
Pain or narrowing that prevents examination or applicator use.

The base may be the problem

The active hormone is only part of a cream. Different products use different vehicles, preservatives, emulsifiers, and inactive ingredients. If irritation starts after a new compound:

Ask for the full inactive-ingredient list.
Compare it with prior products.
Tell the prescriber before switching.
Do not conclude that all vaginal estrogen is intolerable from one cream base.

Symptoms that can look like GSM

An online intake cannot rule out every cause of burning, pain, or itching. Lichen sclerosus, contact dermatitis, vulvodynia, pelvic-floor dysfunction, yeast or bacterial infection, and other vulvar or vaginal conditions can overlap with GSM. If the treatment has not helped, the diagnosis deserves a second look.

Can estriol cream reduce recurrent UTIs?

Local vaginal estrogen is recommended for appropriate peri- and postmenopausal women with GSM and recurrent UTIs because it can reduce future infections. It does not replace testing or treatment for a current infection, and the guideline does not certify every estriol product sold online.

The 2025 AUA/SUFU/AUGS GSM guideline recommends local low-dose vaginal estrogen to reduce future UTIs in women with recurrent UTIs and GSM when there is no contraindication. (AUA GSM guideline)

That means:

A clinician may reasonably discuss local vaginal treatment after repeated infections.
Current symptoms still may need a urine test or acute treatment.
Blood in the urine needs evaluation.
A marketplace cream with no clear intravaginal label is not a guideline-grade substitute.
“Helps reduce future UTIs” is not the same claim as “treats a UTI.”

This distinction matters because several seller pages use “treats recurrent UTIs” as compressed marketing language. The more accurate claim is that local vaginal estrogen can reduce recurrence risk in appropriate women.

Where can you get estriol cream in the United States—and what does it cost?

A U.S. clinician can prescribe patient-specific compounded estriol, but the public market is much less standardized than the search results make it look. Among the programs directly checked for this article, the only telehealth service with a clearly named vaginal estriol product on its public page was Hone Health; its current public cost is $58 per month for the medication plus a required $155 Premium membership. FDA-approved estradiol routes can cost far less.

Every number below was checked on the provider's own public page on August 31, 2026. These are provider-stated commercial facts, not independently audited pharmacy invoices. Prices, eligibility, formularies, and state access can change; confirm the final amount before submitting payment.

Route checked	What it actually offers	Current public price	What is included	What still needs verification
Hone Health vaginal estriol cream	Compounded vaginal estriol; Hone says it is available only in its Premium tier	$58/month medication estimate + $155/month Premium membership = $213/month, plus a currently displayed $65 initial biomarker panel	Clinical program, follow-up visits and follow-up labs under the Premium membership; medication billed separately	Exact estriol concentration, amount per application, tube size, dispensing pharmacy, state availability, and final checkout price. Hone does not pay us.
Alloy estradiol vaginal cream	FDA-approved estradiol vaginal cream 0.01%, 42.5 g	$39.99/month, billed $119.97 every 3 months	Medication, shipping, and unlimited doctor access listed at $0	Individual eligibility, final prescription, contraindications, and whether insurance would be cheaper. Alloy does not pay us.
Midi Health menopause care	Clinician evaluation that can lead to an FDA-approved local or systemic prescription sent to a pharmacy when appropriate	$250 initial self-pay visit; $150 self-pay follow-up, or in-network benefits with many PPO plans	Visits; medication and outside testing are separate unless the plan covers them	Exact pharmacy cost, benefits, state-specific clinician availability, and whether your plan treats Midi as in network. Midi is an affiliate partner.
Sesame menopause subscription	Ongoing menopause telehealth; the clinician may prescribe an appropriate FDA-approved medication	From $59/month; medication is extra	Video visits, unlimited clinician messaging, and basic labs when ordered, with listed state exceptions	Exact medication, pharmacy cost, state availability, and whether the subscription fits federal-program eligibility terms. Sesame is an affiliate partner.
Winona Estrogen Body Cream	Compounded systemic 50/50 estradiol-and-estriol Bi-Est body cream, not vaginal estriol	From $89/month	Online intake, medication, free shipping, no routine hormone testing, and asynchronous physician messaging	Total milligrams of estradiol and estriol per pump, individual prescription, state eligibility, and second-refill price. Winona currently initiates HRT only for ages 35–59 and serves 37 states plus Puerto Rico. Winona is an affiliate partner.

Source: Hone estriol product page, Hone women's pricing, Alloy estradiol vaginal cream, Midi pricing and insurance, Sesame menopause treatment, Sesame Terms of Use, Winona Estrogen Body Cream, and Winona FAQ.

Current cancellation terms matter too. Hone's current women's Premium page says membership cancellation takes effect at the end of the current billing period; a separate billing page says fees already paid are nonrefundable. Sesame says a woman who cancels at least three hours before the initial menopause visit receives a full refund; after that visit, the first month is nonrefundable, and future charges stop only when cancellation occurs before the next billing cycle. Winona says a cancellation request made within 24 hours of payment qualifies for a full refund; after an order is processed, prescription medication cannot be returned. Confirm the deadline shown in your own account before relying on any summary. (Hone women's Premium membership; Hone billing; Sesame menopause refund policy; Winona cancellation and refunds)

The damaging admission, because you should hear it from us

None of our current paid partners publicly lists a vaginal estriol cream that we could verify on the pages reviewed for this article.

Hone does list one, and Hone does not pay us. Its public numbers also give it the highest ongoing monthly total among the clearly identified medication programs in this table: $213 per month before the currently displayed one-time $65 initial panel, with the exact vaginal dose still not stated publicly.

Alloy does not pay us either. It sells an FDA-approved estradiol vaginal cream—not estriol—for $39.99 per month, billed in a three-month supply.

Our paid partners can still fit narrower situations:

Midi fits a woman who wants an insurance-sensitive clinical evaluation and may need both local and systemic treatment.
Sesame fits a cash-pay woman who wants predictable ongoing clinician access and understands that medication is extra.
Winona fits a woman aged 35–59 who has decided she wants a systemic Bi-Est body cream, lives in a served jurisdiction, and understands that the public page gives a ratio but not the milligrams of each estrogen per pump.
Inner Balance should not be presented as a vaginal estriol answer: Oestra is estradiol plus progesterone, while its separate face cream contains estriol.

That is not the affiliate answer with the highest payout. It is the product answer that survives the ingredient check.

Winona's practical strength—and the line you should not cross

Winona's model removes several friction points: no routine hormone testing, no phone or video appointment, free shipping, asynchronous messaging, and a current starting price of $89 per month. The help center says clinician messages are usually answered within 24–48 hours.

The drawback is equally clear: it is a systemic Bi-Est body cream, not a local vaginal estriol product, and the public page does not state the milligrams of each estrogen delivered per pump. Winona's help center also says HRT initiation is limited to ages 35–59 and that a cancellation request must be made within 24 hours of payment for a full refund; after processing begins, medications are not returnable.

Does that sound like your situation—systemic symptoms, age 35–59, a served state, and a deliberate preference for compounded Bi-Est?
Check current Winona eligibility and pricing

If you were searching for local treatment for vaginal dryness or recurrent UTIs, do not let the word “estriol” pull you into a systemic product you did not intend to buy.

What FDA-approved alternatives can treat vaginal menopause symptoms?

The United States has several FDA-approved local options with fixed ingredients, strengths, labels, and manufacturer information: estradiol cream, estradiol inserts or tablets, an estradiol ring, conjugated-estrogen cream, and prasterone for its labeled indication. Approval does not make a product right for everyone, but it makes the product easier to identify and compare.

FDA-approved local option	Active ingredient and labeled strength	Format	Practical difference to discuss
Estradiol vaginal cream 0.01%	Estradiol 0.1 mg/g	Cream with applicator	Flexible cream format; systemic absorption can occur; exact regimen comes from the prescription label
Vagifem / Yuvafem	Estradiol 10 micrograms	Vaginal tablet/insert	Less cream handling; labeled loading and maintenance schedule
Imvexxy	Estradiol 4 or 10 micrograms	Softgel vaginal insert	Applicator-free insert in two strengths
Estring	Estradiol releasing 7.5 micrograms/day for 90 days	Vaginal ring	Long-duration option with less frequent handling
Premarin Vaginal Cream	Conjugated estrogens 0.625 mg/g	Cream with applicator	Different estrogen mixture; label includes a latex/rubber barrier warning
Intrarosa	Prasterone 6.5 mg	Vaginal insert	FDA-approved non-estrogen active ingredient for its labeled indication
Nonhormonal moisturizers and lubricants	Product-dependent	Gel, liquid, suppository, or insert	First-line symptom support for many women; no estrogen exposure

Current product information: estradiol vaginal cream, Vagifem, Imvexxy, Estring, Premarin Vaginal Cream, and Intrarosa.

For the broader format-by-format comparison, see our complete vaginal estrogen guide.

The cost comparison that is fair

Do not compare a retail tube with a clinical subscription as if they contain the same service.

Alloy's current $39.99/month bundles its FDA-approved estradiol cream with online doctor access and shipping, billed every three months.
Midi's $250 initial visit or insurance claim buys a broader menopause evaluation; medication is separate.
Sesame's $59/month subscription buys ongoing care and messaging; medication is separate.
Hone's $213/month current public total buys the Premium program plus its compounded estriol medication; the currently displayed $65 initial panel is separate.
Winona's $89/month starting price includes a compounded systemic body cream and care, not a local vaginal product.

The cheapest route depends on what you actually need: a prescription, ongoing care, a specific dosage form, insurance billing, or a patient-specific compound. A low sticker price is not cheap if it buys the wrong category.

If you need one clinician to decide whether an FDA-approved local product fits—and you are not enrolled in Medicare, Medicaid, TRICARE, or another federal health care program—Sesame currently lists menopause care from $59 per month. Medication is extra.
See current Sesame availability and terms

Is estriol cream covered by insurance, an HSA, or an FSA?

Compounded estriol is often sold through cash-pay programs that do not bill insurance, but “no insurer ever covers it” is too broad. A private plan may reimburse a compounded prescription or an out-of-network visit, while many direct-to-consumer services remain self-pay. HSA or FSA eligibility is a separate tax and plan-administration question, not proof of FDA approval or insurance coverage.

Four different questions get collapsed into the word “covered.”

Question	What it means	What to verify
Does the provider bill insurance?	The clinic submits a claim to your health plan	Network status, visit coding, deductible, and whether the medication is separate
Will the pharmacy benefit cover the drug?	The plan pays all or part of a prescription	Exact product, formulary, prior authorization, compounding benefit, and pharmacy network
Can you seek reimbursement?	You pay first and submit an itemized receipt or superbill	Out-of-network benefits, exclusions, documentation, and deadlines
Can you use HSA/FSA funds?	You use pre-tax money for a qualified medical expense	Plan rules, merchant processing, itemized receipt, and substantiation

Current provider positions

Winona does not bill insurance directly. Its help center says customers may request documentation for possible reimbursement and may use HSA/FSA funds.
Midi is in network with many PPO plans, offers self-pay, and sends prescriptions to a pharmacy when appropriate. It cannot treat Medicaid or Medi-Cal beneficiaries. Medicare beneficiaries may self-pay, but Midi says claims should not be submitted to Medicare.
Sesame does not bill insurance. Its public page says medication and outside labs may still be covered by a plan. Its Terms currently require users to certify that they are not beneficiaries of federal health care programs including Medicare, Medicaid, and TRICARE.
Hone and Alloy publish cash prices; confirm any reimbursement documentation directly before purchase.

The HSA/FSA rule that matters

A seller accepting an HSA or FSA card does not guarantee that every charge is eligible or that your plan administrator will approve it. Current federal tax rules allow reimbursement for many medicines and medical-care expenses, including qualifying over-the-counter medicines; prescription status is not the sole test. Keep the itemized receipt and follow your plan's substantiation process. (IRS Publication 502; IRS Publication 969)

“Takes HSA/FSA” is not the same claim as “takes insurance.” One uses money already in your tax-advantaged account. The other asks an insurer to pay a claim.

Which route fits which woman?

The right starting point changes with the symptom pattern, product route, uterus status, cancer history, insurance, age, state, and how much product certainty you require before paying. There is no honest single winner for every woman. There is a right first branch.

If this is you	Start here	Why
Vaginal symptoms only, and you already have a clinician you trust	Ask about an FDA-approved local option first	Fixed label, strength, manufacturer, and pharmacy path; compounded estriol remains available when a patient-specific need justifies it
Vaginal symptoms only, no clinician, and PPO coverage matters	Midi Health	Available across all 50 states, in network with many PPO plans, and able to prescribe an appropriate FDA-approved product to a pharmacy
Vaginal symptoms only, cash-pay, and you want medication plus online doctor access at a published price	Alloy	Current public price is $39.99/month, billed every three months; FDA-approved estradiol, not estriol; no commission to us
You specifically want compounded vaginal estriol and accept the cost and verification burden	Hone Health	It publicly lists vaginal estriol; current public total is $213/month plus the currently displayed $65 initial panel; exact dose still needs confirmation; no commission to us
You want ongoing cash-pay menopause care and are not a federal-program beneficiary	Sesame	Current subscription starts at $59/month; medication is extra; current Terms exclude Medicare, Medicaid, TRICARE, and other federal-program beneficiaries
Hot flashes and vaginal symptoms	Midi Health or another clinician who treats both	You may need a systemic plan, a local plan, or both rather than one cream expected to do two jobs
Age 35–59, systemic symptoms, served jurisdiction, deliberate preference for compounded Bi-Est	Winona	Streamlined asynchronous care and an $89 starting price; not a vaginal product; ask for milligrams per pump
Age 60 or older with local symptoms	Your clinician or Find My HRT Path	Winona's age cutoff is a company eligibility rule, not a universal ban on local vaginal treatment at 60 or older
Medicare	Your own clinician, an eligible local service, or Find My HRT Path	Midi permits self-pay but says not to submit to Medicare; Sesame's current Terms exclude federal-program beneficiaries
Medicaid or Medi-Cal	Your plan, an in-person clinic, or Find My HRT Path	Midi cannot treat Medicaid/Medi-Cal beneficiaries; Sesame's current Terms exclude federal-program beneficiaries
History of estrogen-dependent cancer or current endocrine therapy	Gynecologist plus oncology team	Nonhormonal treatment first; low-dose vaginal treatment may be considered only through shared decision-making
Any unexplained bleeding after menopause	In-person evaluation before treatment	The diagnosis must come before the product

Not sure which row is yours? Find My HRT Path matches your symptoms, state, insurance, medication route, and safety flags to a starting point—and tells you when online care is not the right first move.

What should you verify before paying for any estriol cream?

Check the treatment against the five things that determine whether the plan holds together: clinical legitimacy, care quality, medication fit, price transparency, and access. The word “estriol” on a product card does not answer any of them.

This is The HRT Index Verification Standard applied to one decision. It is a documented process, not a numeric score.

Clinical legitimacy

Is the prescriber licensed for your state?
Did a clinician review your history before prescribing?
Is the dispensing pharmacy named?
Is the product FDA-approved, compounded, foreign licensed, or unapproved—and is that stated plainly?
Is there a plan for bleeding, side effects, treatment failure, or a diagnosis that needs examination?

Care quality

Can you send a medication question to a clinician?
Is the care asynchronous, live video, or both?
When is the first follow-up?
What happens if nothing improves?
What does the follow-up cost?
Can records be shared with your gynecologist, primary clinician, or oncologist?

Medication fit

Estriol alone, estradiol alone, Bi-Est, DHEA, progesterone, or a mixture?
Vaginal, vulvar, body, or face?
Local or systemic intent?
Milligrams per gram or percentage?
Grams or pumps per application?
Loading schedule and maintenance schedule?
Why this formula instead of an FDA-approved option?
If you have a uterus, what is the endometrial plan?

Price transparency

Initial visit.
Monthly membership.
Medication.
Labs.
Shipping.
Refill frequency.
Introductory price versus ongoing price.
Second-refill price.
Cancellation deadline.
Refund policy.
HSA/FSA documentation.
Insurance or out-of-network claims.

Access

Is your state served?
Are there age restrictions?
Is the pharmacy licensed to dispense to your state?
How long does the first shipment take?
How early must you request a refill?
What happens during a shortage?
Can you move the prescription or records if you leave?

The six questions, in the order to ask them

What exactly is in this—every active ingredient, at what concentration?
How many grams or pumps per application, how often, and when does the schedule step down?
Which pharmacy compounds it, and is that pharmacy licensed to dispense to my state?
Why estriol instead of an FDA-approved product for my symptoms?
If I have a uterus, what is the endometrial-protection and bleeding plan?
What will I be charged at the second refill, and what is the cancellation deadline?

Print them or save them to your phone. A strong provider will answer all six without making you feel difficult for asking.

Bring the questions to the consult instead of trying to decode the prescription afterward.
Get your personalized action plan

When is online care not the right starting point?

Online care is a poor first step when the symptoms need examination, urgent testing, or coordination with a specialist team. Unexplained postmenopausal bleeding, severe or new pelvic pain, suspected infection, blood in the urine, a new breast finding, or a complex cancer history should not be routed directly to a hormone checkout.

We would rather lose the click than have you order a cream for something that needed an examination or biopsy.

See someone in person first for:

Unexplained bleeding after menopause.
Persistent spotting.
Severe or new pelvic pain.
Fever, suspected infection, or unusual/foul-smelling discharge.
Blood in the urine.
A new breast mass or concerning breast change.
Symptoms after gynecologic surgery.
Pain or narrowing that prevents examination or applicator use.
Persistent symptoms despite correctly used treatment.
A cancer history that requires specialist coordination.

Online follow-up may make sense later, after someone has examined you and named the problem. The order matters more than the venue.

What did we actually verify—and what did we not?

We checked the current FDA position, the current 503B bulk-substances list, a live unapproved DailyMed estriol listing, current licensed-product labels, current U.S. approved-product labels, clinical guidance, and provider pages. Commercial facts are labeled provider-stated because a website is evidence of what the company publishes—not independent proof of what every patient receives.

Evidence block	What we checked	Verification status
U.S. estriol status	FDA menopause guidance, compounding Q&A, NDC guidance, and the FDA 503B bulk-substances document	Direct primary-source verification
Unapproved commercial listing	DailyMed entry showing micronized estriol 0.1%, “Human OTC Drug Label,” “unapproved drug other,” and external-only directions	Direct label verification; one current example, not every seller
Licensed foreign products	Blissel, Estriol 1 mg/g cream, and Ovesse official labels	Direct product-specific verification
Licensed dose comparison	Converted 0.005% at 1 g to 0.05 mg and 1 mg/g at 0.5 g to 0.5 mg	Arithmetic shown; 10-fold labeled-dose difference
Medical guidance	The Menopause Society, ACOG, AUA/SUFU/AUGS, British Menopause Society, and peer-reviewed evidence	Direct guidance or publication review
FDA-approved U.S. alternatives	Current DailyMed labels for estradiol cream, inserts, ring, Premarin, and Intrarosa	Direct label verification
Provider prices and terms	Hone, Alloy, Midi, Sesame, Winona, and Inner Balance public pages	Provider-stated, checked August 31, 2026
Editorial recommendations	Matched route, symptom pattern, regulation, cost, access, and evidence	The HRT Index editorial conclusion, not a medical order

What we did not do

We did not buy or use an estriol product.
We did not obtain a prescription.
We did not test a cream in a laboratory.
We did not inspect a dispensed Hone, Winona, or other compounded label.
We did not independently confirm a provider's pharmacy lot, potency, sterility, or content.
We did not call every insurer or state board.
We did not medically review this page with a clinician.
We did not use customer testimonials as proof that a medication works.
We did not assign invented numeric scores.

The HRT Index Verification Standard

Under The HRT Index Verification Standard, we read every published price, separate FDA-approved from compounded, verify state availability and insurance, and re-check on a fixed schedule: top providers monthly, the full roster quarterly.

The page is evaluated through the same five pillars every time, in this order:

Clinical legitimacy
Care quality
Medication fit
Price transparency
Access

If a provider changes a price, age rule, state list, pharmacy, formulation, or policy, the dated commercial claim needs to change with it.

Why there are no product testimonials here

A customer quote saying a hormone “worked” functions as an efficacy claim. The exact U.S. compounds in this article are not FDA-approved, public dose information is incomplete, and one person's symptom result cannot establish the effect of a different formula in another woman.

So we are not borrowing a dramatic result from a review carousel.

The questions women ask are more useful:

“Is estriol the same as estradiol?”
“Does this go inside or outside?”
“Is Bi-Est the same product?”
“Does local estrogen still get into the blood?”
“Why won't the seller show the dose?”
“Can an NDC number be unapproved?”
“Can I get an approved option instead?”

Those are the questions the page should answer before it asks for a click.

Found something outdated or wrong? Send the product page, label, or policy document. Corrections should be dated and visible.

What is the bottom line on estriol cream for menopause?

Estriol is a real estrogen with evidence in specific studied and licensed vaginal products, but no estriol-containing drug is FDA-approved in the United States. A U.S. compounded prescription may be reasonable for a documented patient-specific need. An unapproved marketplace listing is not the same thing, and a Bi-Est body cream is not a vaginal cream.

Before paying, get straight answers to two questions:

What is the concentration of every active ingredient?
How many grams or pumps are used per application?

Without both numbers, you do not know the dose.

For a U.S. woman with vaginal dryness, pain with sex, urinary symptoms, or recurrent UTIs—and no patient-specific reason that an approved option cannot meet—the most verifiable starting discussion is usually an FDA-approved local product with a fixed label. That is not because estriol is fake. It is because the ingredient, strength, manufacturer, route, warnings, and dispensing path can all be checked before treatment begins.

For a woman with a clear reason for compounded estriol, the right move is not blind trust and not automatic rejection. It is a named prescriber, a named pharmacy, a complete formula, a patient-specific reason, and a follow-up plan.

Still not sure which HRT program is right for you? Take our free matching quiz. It takes about 90 seconds and does not require an email.

Start Find My HRT Path

Frequently asked questions about estriol cream for menopause

These are the direct answers to the follow-up questions most likely to stop a woman before a consult or purchase. Each answer preserves the same product boundaries used above: FDA-approved, compounded, foreign licensed, and unapproved are not interchangeable categories.

Is estriol cream FDA-approved?

No. The FDA states that no drug containing estriol is FDA-approved in the United States. A compounded prescription, NDC number, DailyMed page, or licensed foreign product does not change that U.S. status. (FDA menopause guidance)

Is estriol cream available over the counter in the United States?

There is no FDA-approved over-the-counter estriol drug in the United States. Unapproved products can still appear online and in drug-label databases. A current DailyMed entry, for example, labels micronized estriol 0.1% as a “Human OTC Drug Label” while also marking its marketing status “unapproved drug other.” That is availability without approval. (DailyMed example)

Is every U.S. estriol cream compounded?

No. A legitimate U.S. prescription estriol cream is generally compounded for a patient, but unapproved commercial listings also exist. The accurate dividing line is not “compounded versus nonexistent.” It is patient-specific compounded prescription versus unapproved commercial product versus licensed foreign medicine.

Is estriol the same as estradiol?

No. Estriol and estradiol are different estrogens. FDA-approved vaginal estradiol products exist in the United States; no FDA-approved estriol product does. Do not convert between them with an online potency ratio because concentration, application amount, route, frequency, and formulation determine the actual exposure.

Is estriol safer or gentler than estradiol?

The word “gentler” does not establish safety. Estriol is often described as a weaker estrogen, but route and dose can change systemic exposure, and a vaginal pharmacokinetic study found wide variation in serum estriol after a 0.5 mg application. The FDA says it has no evidence that estriol drugs are safer forms of estrogen. (FDA menopause guidance; te West et al.)

What is the American version of Ovestin?

There is no FDA-approved U.S. estriol counterpart. Current UK products such as Estriol 1 mg/g cream and Ovesse are licensed there under their own labels. U.S. choices are a patient-specific compounded estriol prescription or a different FDA-approved local product such as estradiol cream, an estradiol insert or ring, Premarin Vaginal Cream, or Intrarosa.

Is Bi-Est the same as vaginal estriol cream?

No. Bi-Est is a compounded mixture of estradiol and estriol. It is commonly sold as a skin-applied systemic body cream for whole-body menopause symptoms. A low-dose vaginal estriol product is intended for local genital and urinary symptoms. The route, dose, progesterone question, and risk discussion are different.

Is Oestra an estriol cream?

No. Inner Balance currently describes Oestra as a compounded vaginally administered systemic cream containing 3 mg estradiol and 100 mg micronized progesterone per pump. Its separate facial product contains 0.3% estriol. Product names and card headings are not substitutes for the active-ingredient list.

What strength should estriol vaginal cream be?

There is no universal U.S. answer. Licensed products show why: Blissel delivers 0.05 mg per labeled application, while current 1 mg/g estriol creams deliver 0.5 mg from a 0.5 g application—a 10-fold difference. Your prescription needs both the concentration and the amount per application.

How long does estriol cream take to work?

Current licensed-product information describes improvement over several days to several weeks. Dryness or surface irritation may change before pain with sex or urinary symptoms. Follow the planned review schedule; do not increase the dose on your own if relief is slow.

Can estriol cream be used long term?

GSM symptoms often return after local treatment stops, so maintenance may be ongoing. Duration depends on the exact product, symptom response, medical history, and follow-up. Use the lowest appropriate regimen established with the prescriber, and report new bleeding rather than treating it as an expected long-term effect.

Does vaginal estriol enter the bloodstream?

Some does. “Local” describes the treatment target; it does not mean zero absorption. A 2021 pharmacokinetic study of long-term users receiving 0.5 mg vaginal estriol found that serum concentrations peaked about two hours after use and varied widely between women. (te West et al.)

Do you need progesterone with vaginal estriol cream?

Routine progestogen is generally not recommended with a genuinely low-dose local vaginal regimen, but that guidance assumes the route and dose are known. A systemic Bi-Est body cream is a different question. If you have a uterus, ask whether the product is local or systemic, what dose is being delivered, and what the endometrial and bleeding plan is.

Can you use estriol cream after breast cancer?

This requires shared decision-making, not a blanket website answer. Current ACOG guidance says low-dose vaginal estrogen may be considered after nonhormonal treatments fail; for someone taking an aromatase inhibitor, the decision should involve the patient, gynecologist, and oncologist. Evidence from a specific ultra-low-dose product cannot be transferred automatically to an unknown compound. (ACOG Clinical Consensus)

Does estriol vaginal cream help hot flashes?

A low-dose local vaginal product is not a treatment for hot flashes or night sweats. Those symptoms require a systemic hormonal or nonhormonal discussion. A Bi-Est body cream is marketed as systemic treatment, but it is a different product category from vaginal estriol.

Can you use local vaginal treatment alongside systemic HRT?

Sometimes. A woman can have whole-body symptoms and persistent GSM at the same time. Every prescriber should know every hormone product being used—including patches, pills, gels, body creams, vaginal products, and face creams—so that routes and total exposure are not accidentally duplicated.

Is estriol face cream the same as vaginal estriol cream?

No. Face creams and vaginal products use different concentrations, bases, directions, and treatment goals. Do not use a face product internally or a vaginal product on the face unless the actual prescription label and prescriber direct that route.

Does estriol cream weaken condoms or diaphragms?

The answer is product-specific. The FDA-approved Premarin Vaginal Cream label warns that its product may weaken latex or rubber condoms, diaphragms, and cervical caps. That does not prove the same effect for every compounded estriol base. Ask the dispensing pharmacy if you rely on a barrier method.

Why does vaginal cream leak out?

Some leakage can occur with a cream format. Bedtime use and a liner may make it easier when those steps fit the label. Heavy leakage, pain, or uncertainty that the dose was delivered should be discussed with the prescriber rather than corrected with an extra dose.

Can insurance cover compounded estriol cream?

Sometimes, but coverage is inconsistent. Many direct-to-consumer compounders do not bill insurance, while a private plan may allow a pharmacy claim, reimbursement, or an out-of-network submission depending on the benefit and documentation. Confirm the exact compound, pharmacy, network, and plan rules before assuming either coverage or exclusion.

Can you use an HSA or FSA for estriol treatment?

A qualifying visit or medication may be eligible, but card acceptance is not a guarantee. HSA and FSA rules require the expense and documentation to meet applicable tax and plan requirements. Keep an itemized receipt and follow the administrator's substantiation process.

Does an NDC number mean an estriol product is FDA-approved?

No. The FDA states that NDC assignment or listing does not denote approval. Check the product's marketing status and an actual FDA approval database rather than treating the number as a seal of safety or effectiveness. (FDA NDC Directory)

Where can you get compounded vaginal estriol online?

Hone Health currently publishes a vaginal estriol product at $58 per month, available through a required $155 Premium membership, plus a currently displayed $65 initial biomarker panel. The exact strength, application amount, tube size, pharmacy, state access, and checkout total still need confirmation before payment. Hone does not pay us.

Primary sources and product pages used

Medical and regulatory claims above trace to FDA materials, official drug labels, clinical guidance, and peer-reviewed publications. Commercial claims trace to provider-owned pages checked on August 31, 2026 and remain provider-stated until confirmed through the actual intake, prescription, pharmacy, or checkout flow.

U.S. regulation and labels

Licensed estriol products outside the United States

Clinical guidance and peer-reviewed evidence

Commercial facts checked August 31, 2026

Keep comparing the route, product, and care model.

Read the complete vaginal estrogen guide, compare online HRT providers, review compounded versus FDA-approved HRT, or use Find My HRT Path.

Keep reading: